Vaccine Manufacturing, Scaling, Supply Chain, and Administration Issues
Recorded February 4, 2021 | On-Demand Webinar
Once a vaccine is ready for market, a company must adhere to continuing manufacturing, reporting, inspection, and other requirements. The sponsor company must also scale up production in preparation for widespread distribution and ensure that components and other materials used in the manufacturing process are readily available. Lastly, the vaccine must be distributed, stored, and administered to the population. This session will describe the different requirements at play, utilizing COVID-19 vaccine-related practical examples and considerations.
This session was recorded as part of FDLI’s virtual course, "Fundamentals of Vaccine Regulation: Scientific Ingenuity and Rigorous Review" in February 2021.